About the Authors

Toby Leslie, Christopher J. M. Whitty, Mark Rowland
Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom

Toby Leslie, Ismail Mayan, Nasir Mohammed
HeathNet TPO, Peshawar, North West Frontier Province, Pakistan

Marnie Briceño, Carol Hopkins Sibley
Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America

Eveline Klinkenberg
HealthNet TPO, Amsterdam, The Netherlands

Corresponding Author

toby.leslie@lshtm.ac.uk

Competing Interests

Other than the partial funding by GlaxoSmithKline of this investigator-initiated study, CJMW has received funding for investigator -initiated research from Pfizer. None of the other authors have conflicts of interest to declare.

Author Contributions

ICMJE criteria for authorship read and met: TL MB IM NM EK CHS CJMW MR. Agree with the manuscript's results and conclusions: TL MB IM NM EK CHS CJMW MR. Designed the experiments/the study: TL IM EK CJMW MR. Analyzed the data: TL MB EK CHS CJMW MR. Collected data/did experiments for the study: TL MB IM NM CHS. Enrolled patients: NM. Wrote the first draft of the paper: TL. Contributed to the writing of the paper: TL MB IM EK CHS CJMW MR. Planned and executed molecular analysis, analyzed molecular data, and edited final draft: CHS.